If you are taking Wegovy, Ozempic or Mounjaro and are facing an upcoming surgery — or you have wondered whether your medication affects how your body heals cuts, incisions or ulcers — you are not alone. This is an area that doctors and researchers are paying increasing attention to, and the early results are genuinely encouraging.

At the same time, there are important practical considerations around surgery and GLP-1 medication that you need to discuss with your doctor. This article covers both sides.

What does the research say about GLP-1 and wound healing?

The most compelling evidence comes from a large observational study conducted by researchers at Weill Cornell Medicine and NewYork-Presbyterian Hospital, published in the Annals of Surgery in late 2024. The study examined 21,772 patients with diabetes who underwent a total of 74,425 surgical procedures.

Patients taking GLP-1 receptor agonists (including semaglutide and tirzepatide) had significantly better surgical wound outcomes than those not taking these medications:

These are striking differences. The researchers controlled for many potential confounders, making the results more credible — though, as with any observational study, definitive causation cannot be established without randomised controlled trials.

A second area of active research is diabetic foot ulcers — one of the most difficult wound-healing challenges in medicine. A 2025 retrospective cohort study in Diabetes and Vascular Disease Research examined the impact of semaglutide on patients with diabetic foot ulcers over a ten-year period. The results suggest that semaglutide may support better outcomes in this population, likely through improved glucose control and anti-inflammatory effects.

Why might GLP-1 medications improve wound healing?

Several biological mechanisms may explain the beneficial effects:

Anti-inflammatory effects

Wound healing depends critically on a balanced inflammatory response. Too much inflammation — as often seen in obesity and diabetes — impairs the healing process. GLP-1 receptor agonists have well-documented anti-inflammatory effects: they reduce levels of cytokines like TNF-α and IL-6 that can interfere with tissue repair. By dampening excessive inflammation, they may create a more favourable environment for healing.

Better blood sugar control

High blood glucose is one of the most damaging factors for wound healing. Elevated glucose impairs white blood cell function, damages blood vessel walls, reduces collagen synthesis, and increases the risk of infection. All of these effects slow healing significantly. GLP-1 medications — especially for people with type 2 diabetes or prediabetes — can substantially improve glycaemic control, directly benefiting wound biology.

Improved circulation and endothelial function

Good wound healing requires adequate blood supply to deliver oxygen, nutrients and immune cells to the damaged tissue. GLP-1 receptors are found in blood vessel walls, and research suggests that GLP-1 agonists improve endothelial function — the health and responsiveness of the inner lining of blood vessels. Better circulation means better healing.

Reduced mechanical tension on wounds

This one is practical and often overlooked. When a person loses significant weight before surgery, there is simply less mechanical stress on abdominal and other incisions. A wound under constant tension is harder to close and more likely to re-open. For people who have lost 15–20% of their body weight on GLP-1 medication before elective surgery, this mechanical benefit may be significant.

Important: GLP-1 and surgery — what you must know

While the news about wound healing is encouraging, there is a critical practical issue that everyone taking GLP-1 medication must be aware of before any surgery.

GLP-1 medications slow gastric emptying — they deliberately delay the rate at which the stomach empties its contents into the intestine. This is part of how they create satiety. However, this effect does not switch off simply because you stopped eating the night before surgery.

If the stomach still contains food or liquid during general anaesthesia, there is a risk of pulmonary aspiration — stomach contents entering the lungs. This is a serious anaesthetic complication.

The American Society of Anesthesiologists (ASA) therefore recommends pausing GLP-1 medications before elective surgery:

Always discuss this with both your prescribing doctor and your anaesthetist well in advance of any planned surgery. Do not stop your medication without medical guidance.

This caution about stopping GLP-1 before surgery is entirely separate from the wound-healing benefits described above — which relate to the medication's effects during the recovery period after surgery.

What about diabetic foot ulcers specifically?

Diabetic foot ulcers affect an estimated 15–25% of people living with diabetes over their lifetime and are the leading cause of non-traumatic leg amputations. They are notoriously difficult to heal, largely because of the combination of poor blood supply, nerve damage and high glucose levels that are common in diabetes.

The emerging evidence that semaglutide may improve outcomes in this population is therefore particularly meaningful. While the evidence is still preliminary — and certainly should not be taken as an endorsement for self-treating foot ulcers — it adds to the growing picture of GLP-1 medications having benefits that extend well beyond simple weight loss.

If you have diabetes and any foot wound or ulcer, seek medical attention promptly. Do not wait to see if it heals on its own.

What are the limitations of current evidence?

It is important to be honest about the state of the evidence:

The current evidence is promising but not definitive. Think of it as a strong signal worth watching — not a proven guarantee.

What does this mean for you?

If you are taking Wegovy, Ozempic or Mounjaro, there is reason to be cautiously optimistic about wound healing. The biological mechanisms are sound, the observational evidence is encouraging, and the benefits of better blood sugar control and reduced inflammation extend into virtually every aspect of physical health — including how your body repairs itself.

The most important action you can take is to communicate openly with your healthcare team about any upcoming procedures, any wounds that are slow to heal, and any questions about how your medication interacts with surgery or recovery.

This article is for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider about your individual treatment and any planned surgical procedures.

Sources